Atlas Trials

A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T

Clinical trial NCT02232230 · COMPLETED

Trial details

NCT number
NCT02232230
Sponsor
GenesisCare USA
Status
COMPLETED
Study type
OBSERVATIONAL
Castrate Refractory Metastatic Prostate Cancer (mCRPC)
Start date
2014-06-01
Primary completion
2018-06-05
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.